{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T06:14:13Z","timestamp":1785046453115,"version":"3.55.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Rubella is a very diffusive but relatively benign infectious disease unless contracted during pregnancy, when it causes congenital rubella syndrome. The aim of this research was to determine the prevalence and titer of antirubella antibodies in a population of future healthcare workers (students at the school of medicine).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The cohort consisted of 11,022 students who underwent antibody analysis after the presentation of a vaccine certificate.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Vaccination compliance was very high, particularly in younger students (born after 1995), reaching almost 100% (at least one dose). Unvaccinated students born before 1990 had high seropositivity (&amp;gt;95%), but this percentage dropped to zero among the youngest students. Variables affecting antibody titer included year of birth and sex. Considering only vaccinated students, a greater antibody response was observed if the vaccine was administered between 8 and 10 years of age. Female sex was associated with more significant (<jats:italic>p<\/jats:italic> &amp;lt; 0.0001) positivity and higher antibody titer after one and two doses. However, this difference appeared less consistent in relation to year of birth.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> The studied population exhibited excellent vaccination compliance, high seropositivity, and high antibody titer. Vaccine and immune coverage were higher than what is deemed necessary to achieve herd immunity.<\/jats:p>","DOI":"10.3389\/fpubh.2021.741178","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T04:59:20Z","timestamp":1631509160000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Rubella Serosurvey Among Future Healthcare Workers"],"prefix":"10.3389","volume":"9","author":[{"given":"Andrea","family":"Trevisan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Nicolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Maso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bertoncello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"B1","volume-title":"Circolare n. 12. Controllo ed eliminazione di morbillo, parotite e rosolia per mezzo della vaccinazione (Circular 12. Control and Elimination of Measles, Mumps and Rubella by Means of Vaccination)","year":"1999"},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2807\/esm.09.04.00462-en","article-title":"Rubella control in Italy","volume":"9","author":"Ciofi degli Atti","year":"2004","journal-title":"Euro Surveill"},{"key":"B3","unstructured":"Rosolia Congenita e in Gravidanza (Congenital Rubella and During Pregnancy)2018"},{"key":"B4","volume-title":"Piano Nazionale Prevenzione Vaccinale 2017-2019 (National Vaccination Prevention Plan 2017-2019)","year":"2017"},{"key":"B5","unstructured":"Global Measles and Rubella Strategic Plan 2012-2020. WHO Library Cataloguing-in-Publication Data. Printed in Switzerland2012"},{"key":"B6","volume-title":"Disposizioni Urgenti in Tema di Prevenzione Vaccinale (Law Decree N. 73. Urgent Provisions on Vaccine Prevention)","year":"2017"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/archpedi.1979.02130120023001","article-title":"Rubella immunization now","volume":"133","author":"Balfour","year":"1979","journal-title":"Am J Dis Child"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1016\/S0264-410X(00)00139-0","article-title":"Duration of rubella immunity induced by two-dose Measles, Mumps and Rubella (MMR) vaccination. A 15-year follow-up in Finland","volume":"18","author":"Davidkin","year":"2000","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(88)92512-3","article-title":"Rubella vaccination: persistence of antibodies for 10-21 years","volume":"332","author":"O'Shea","year":"1988","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2807\/esm.09.04.00459-en","article-title":"Epidemiology of rubella in Finland","volume":"9","author":"Davidkin","year":"2004","journal-title":"Euro Surveill"},{"key":"B11","first-page":"1","article-title":"Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","year":"1999","journal-title":"Mobid Mortal Weekly Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0140-6736(90)90420-A","article-title":"Immunisation and herd immunity","volume":"335","author":"Anderson","year":"1990","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"7992","DOI":"10.3390\/ijerph17217992","article-title":"rubella immunity among italian female healthcare workers: a serological study","volume":"17","author":"Coppeta","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.vaccine.2005.07.062","article-title":"Prevalence of childhood exanthematic disease antibodies in paramedical students: need of vaccination","volume":"24","author":"Trevisan","year":"2006","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1086\/516657","article-title":"Immunity against infectious diseases: predictive value of self-reported history of vaccination and disease","volume":"28","author":"Trevisan","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1016\/j.vaccine.2019.05.049","article-title":"Seroprevalence and durability of rubella virus antibodies in a highly immunized population","volume":"37","author":"Crooke","year":"2019","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jiph.2020.01.309","article-title":"Seroepidemiology of hepatitis viruses, measles, mumps, rubella and varicella among healthcare workers and students: should we screen before vaccination?","volume":"13","author":"Karadeniz","year":"2020","journal-title":"J Infect Public Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/vaccines8010104","article-title":"Will we have a cohort of healthcare workers fully vaccinated against measles, mumps, and rubella?","volume":"8","author":"Trevisan","year":"2020","journal-title":"Vaccines"},{"key":"B19","unstructured":"30116Wkly Epidemiol Rec862011"},{"key":"B20","unstructured":"30624Wkly Epidemiol Rec952020"},{"key":"B21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/vaccines9040377","article-title":"Vaccination and immunity towards measles: a serosurvey in future healthcare workers","volume":"9","author":"Trevisan","year":"2021","journal-title":"Vaccines"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1016\/j.vaccine.2016.06.002","article-title":"A 16-year review of seroprevalence studies on measles and rubella","volume":"34","author":"Dimech","year":"2016","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12879-017-2724-y","article-title":"Lack of immunity against rubella among italian young adults","volume":"17","author":"Gallone","year":"2017","journal-title":"BMC Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1016\/j.vaccine.2008.04.054","article-title":"Sexual dimorphism of humoral immunity with human vaccines","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1016\/j.vaccine.2009.01.086","article-title":"Gender effects on humoral immune responses to smallpox vaccine","volume":"27","author":"Kennedy","year":"2009","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/21645515.2019.1656483","article-title":"Significance of anti-HB levels below 10 IU\/L after vaccination against hepatitis B in infancy or adolescence: an update in relation to sex","volume":"16","author":"Trevisan","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1016\/j.vaccine.2019.06.055","article-title":"Comparison of antibody response between boys and girls after infant and childhood vaccinations in the Netherlands","volume":"37","author":"Hoes","year":"2019","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijid.2020.04.082","article-title":"Varicella seroepidemiology and immunization in a cohort of future healthcare workers in the pre-vaccination era","volume":"96","author":"Trevisan","year":"2020","journal-title":"Int J Infect Dis"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2021.741178\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T04:59:35Z","timestamp":1631509175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2021.741178\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":29,"alternative-id":["10.3389\/fpubh.2021.741178"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2021.741178","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"article-number":"741178"}}